Impact of multi-approach strategy on acid suppressive medication use in a teaching hospital in Qatar

International Journal of Clinical Pharmacy

Volumn 33, Issue 5, 2011, Pages 763-771

  Khudair, Imran F ^a   Sadik, Nagham D ^a   Hanssens, Yolande ^a   Muhsin, Saif A ^a   Matar, Issa ^a  

^a HAMAD GENERAL HOSPITAL   (Qatar)

Author keywords

Acid suppressive medications; Drug use; Prescribing intervention; Qatar; Teaching hospital

Indexed keywords

ACID SUPPRESSIVE MEDICATION; LANSOPRAZOLE; OMEPRAZOLE; RABEPRAZOLE; RANITIDINE; STOMACH SECRETION INHIBITOR; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ACUTE PANCREATITIS; ADOLESCENT; ADULT; ARTICLE; DIGESTIVE SYSTEM ULCER; DRUG USE; DRUG UTILIZATION; DYSPEPSIA; FEMALE; FOLLOW UP; GASTROESOPHAGEAL REFLUX; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; INTERVENTION STUDY; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; MEDICATION ERROR; PRIORITY JOURNAL; PROSPECTIVE STUDY; QATAR; TEACHING HOSPITAL; UPPER GASTROINTESTINAL BLEEDING; VOMITING;

ADOLESCENT; ADULT; FEMALE; HEALTH SERVICES MISUSE; HISTAMINE H2 ANTAGONISTS; HOSPITALS, TEACHING; HUMANS; MALE; MIDDLE AGED; PHARMACY SERVICE, HOSPITAL; PHYSICIAN'S PRACTICE PATTERNS; PROGRAM DEVELOPMENT; PROGRAM EVALUATION; PROSPECTIVE STUDIES; PROTON PUMP INHIBITORS; QATAR;

EID: 83255191682     PISSN: 22107703     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11096-011-9531-0     Document Type: Article

References (25)

1. Khudair IF, Sadik ND, Hanssens Y. Prescribing pattern of acid suppressive medications for medical inpatients in a teaching hospital in Qatar. Saudi Med. J. 2009;30:125-9.
2. Pham CQ, Regal RE, Bostwick TR, Knauf KS. Acid suppressive therapy use on an inpatient internal medicine service. Ann. Pharmacother. 2006;40:1261-6. (Pubitemid 44204954)
3. Heidelbaugh JJ, Inadomi JM. Magnitude and economic impact of inappropriate use of stress ulcer prophylaxis in non-ICU hospitalized patients. Am. J. Gastroenterol. 2006;101:2200-5. (Pubitemid 44477543)
4. Grube RR, May DB. Stress ulcer prophylaxis in hospitalized patients not in intensive care units. Am. J. Health Syst. Pharm. 2007;64:1396-400. (Pubitemid 47025538)
5. Mayet AY. Improper use of antisecretory drugs in a tertiary care teaching hospital: an observational study. Saudi J. Gastroenterol. 2007;13:124-8.
6. Sklendar SJ, Culley CM. Collaboratively designed practice guidelines promote appropriate use of intravenous proton pump inhibitors. Hosp. Pharm. 2005;40:497-504. (Pubitemid 41246355)
7. Cahir C, Fahey T, Teeling M, Teljeur C, Feely J, Bennett K. Potentially inappropriate prescribing and cost outcomes for older people: a national population study. Br. J. Clin. Pharmacol. 2010;69:543-52.
8. Regal RE, Osta AD, Parekh VI. Interventions to curb the overuse of Acid-suppressive medications on an inpatient general medicine service. P. T. 2010;35:86-90.
9. Smeets HM, Hoes AW, de Wit NJ. Effectiveness and costs of implementation strategies to reduce acid suppressive drug prescriptions: a systematic review. BMC Health Serv. Res. 2007;7:177.
10. Ahrens D, Chenot JF, Behrens G, Grimmsmann T, Kochen MM. Appropriateness of treatment recommendations for PPI in hospital discharge letters. Eur. J. Clin. Pharmacol. 2010;66:1265-71.
11. Leontiadis GI, Sharma VK, Howden CW. Systematic review and meta-analysis of proton pump inhibitor therapy in peptic ulcer bleeding. BMJ. 2005;330:568.
12. ASHP Therapeutic Guidelines on Stress Ulcer Prophylaxis. ASHP Commission on Therapeutics and approved by the ASHP Board of Directors on November 14, 1998. Am. J. Health Syst. Pharm. 1999;56:347-79.
13. Skála I, Marecková O, Vítko S, Matl I, Lácha J. Prophylaxis of acute gastroduodenal bleeding after renal transplantation. Transpl. Int. 1997;10:375-8. (Pubitemid 27352827)
14. Chen LS, Lin HC, Hwang SJ, Lee FY, Hou MC, Lee SD. Prevalence of gastric ulcer in cirrhotic patients and its relation to portal hypertension. J. Gastroenterol. Hepatol. 1996;11:59-64.
15. Piper JM, Ray WA, Daugherty JR, Griffin MR. Corticosteroid use and peptic ulcer disease: role of non steroidal anti-inflammatory drugs. Ann. Intern. Med. 1991;114:735-40.
16. Lanza FL. A guideline for the treatment and prevention of NSAID-induced ulcers Members of the Ad Hoc Committee on Practice Parameters of the American College of Gastroenterology. Am. J. Gastroenterol. 1998;93:2037-46.
17. Grindrod KA, Patel P, Martin JE. What interventions should pharmacists employ to impact health practitioners' prescribing practices? Ann. Pharmacother. 2006;40:1546-57. (Pubitemid 44330199)
18. The Definition of Clinical Pharmacy. American College of Clinical Pharmacy Available at: http://www.accp.com/docs/ positions/commentaries/ Clinpharmdefnfinal.pdf. Accessed on 3 May 2011.
19. van Vliet EP, Steyerberg EW, Otten HJ, Rudolphus A, Knoester PD, Hoogsteden HC, et al. The effects of guideline implementation for proton pump inhibitor prescription on two pulmonary medicine wards. Aliment. Pharmacol. Ther. 2009;29:213-21.
20. Heidelbaugh JJ, Goldberg KL, Inadomi JM. Adverse risks associated with proton pump inhibitors: a systematic review. Gastroenterol. Hepatol. (NY). 2009;5:725-34.
21. Rollason V, Vogt N. Reduction of polypharmacy in the elderly: a systematic review of the role of the pharmacist. Drugs Aging. 2003;20:817-32. (Pubitemid 37159599)
22. Finley PR, Crismon ML, Rush AJ. Evaluating the impact of pharmacists in mental health: a systematic review. Pharmacotherapy. 2003;231634-44.
23. Batuwitage BT, Kingham JG, Morgan NE, Bartlett RL. Inappropriate prescribing of proton pump inhibitors in primary care. Postgrad. Med. J. 2007;83:66-8.
24. Thomson O'Brien MA, Oxman AD, Davis DA, Haynes RB, Freemantle N, Harvey EL. Educational outreach visits: effects on professional practice and health care outcomes. Cochrane Database Syst. Rev. 2000;2: CD000409.
25. Thomson O'Brien MA, Oxman AD, Haynes RB, Davis DA, Freemantle N, Harvey EL. Local opinion leaders: effects on professional practice and health care outcomes. Cochrane Database Syst Rev. 2000;2:CD000125.